Effect of Direct-acting Antiviral Drugs on Erectile Function

Sherief Abd-Elsalam

Status and phase: Unknown; Phase 3

Conditions: Hepatitis C

Treatments: Drug: Sofosbuvir and Daklatasuvir

Study type: Interventional

Funder types: Other

Identifiers

NCT03444272

HCV TREATMENT

Details and patient eligibility

About

Effect of direct-acting antiviral drugs on erectile function

Full description

Effect of direct-acting antiviral drugs on erectile function in HCV patients

Enrollment: 105 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HCV infected patients
• Male

Exclusion criteria

• HCC
• Age below 18 years

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

105 participants in 2 patient groups

Hepatitis C Treatment

Experimental group

Description:

HCV Treatment (Sofosbuvir and Daklatasuvir)

Treatment:

Drug: Sofosbuvir and Daklatasuvir

Supportive treatment

No Intervention group

Description:

supportive liver therapy